Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $1.1 million.

  • Rapid Micro Biosystems' Share-based Compensation rose 2335.84% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 266.22%. This contributed to the annual value of $3.9 million for FY2024, which is 1844.21% down from last year.
  • Latest data reveals that Rapid Micro Biosystems reported Share-based Compensation of $1.1 million as of Q3 2025, which was up 2335.84% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Share-based Compensation registered a high of $1.3 million during Q2 2022, and its lowest value of $191000.0 during Q1 2021.
  • Moreover, its 5-year median value for Share-based Compensation was $1.0 million (2025), whereas its average is $941684.2.
  • Per our database at Business Quant, Rapid Micro Biosystems' Share-based Compensation skyrocketed by 41465.97% in 2022 and then tumbled by 3258.32% in 2024.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Share-based Compensation stood at $678000.0 in 2021, then soared by 62.98% to $1.1 million in 2022, then fell by 7.51% to $1.0 million in 2023, then crashed by 32.58% to $689000.0 in 2024, then soared by 66.33% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.2 million for Q2 2025, and $1.0 million during Q1 2025.